Literature DB >> 17565220

Peripheral blood markers of oxidative stress in Parkinson's disease.

S Younes-Mhenni1, M Frih-Ayed, A Kerkeni, M Bost, G Chazot.   

Abstract

Oxidative stress and generation of reactive oxygen species are believed to be implicated in Parkinson's disease (PD). Erythrocyte activity of superoxide dismutase (SOD) and catalase, the blood glutathione system, and plasma levels of thiobarbituric-acid-reactive substances (TBARS) were measured in 80 PD patients. These biochemical parameters were also measured in 29 age-matched controls. Patients with PD had significantly higher red blood corpuscle (RBC) activity of SOD. The mean RBC activity of catalase in PD patients did not differ significantly from those of controls. RBC catalase activity was significantly lower in advanced cases of PD compared to early cases. Oxidized glutathione was significantly higher in RBCs of PD patients, although there were no changes in total glutathione and reduced glutathione compared to controls. TBARS content was increased in patients with PD. Levodopa therapy, age and duration of illness did not significantly influence the measured parameters. Our study supports the previous hypothesis that oxidative stress is implicated in the pathogenesis of PD. Perspectives for treatment of PD in the future could include antioxidant therapy. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565220     DOI: 10.1159/000103641

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  23 in total

Review 1.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

Review 2.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

Authors:  G Watfa; C Dragonas; T Brosche; R Dittrich; C C Sieber; C Alecu; A Benetos; R Nzietchueng
Journal:  J Nutr Health Aging       Date:  2011-04       Impact factor: 4.075

4.  Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Authors:  Shiek Ssj Ahmed; Winkins Santosh; Suresh Kumar; Hema T Thanka Christlet
Journal:  J Biomed Sci       Date:  2009-07-13       Impact factor: 8.410

Review 5.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

6.  Systemic oxidative stress associated with the neurological diseases of aging.

Authors:  Jorge A Serra; Raúl O Domínguez; Enrique R Marschoff; Eduardo M Guareschi; Arturo L Famulari; Alberto Boveris
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 7.  Emerging candidate biomarkers for Parkinson's disease: a review.

Authors:  Enrico Saracchi; Silvia Fermi; Laura Brighina
Journal:  Aging Dis       Date:  2013-10-09       Impact factor: 6.745

8.  Oxidative and nitrosative stress in serum of patients with Parkinson's disease.

Authors:  Hikmet Can Çubukçu; Mustafa Yurtdaş; Zahide Esra Durak; Bilal Aytaç; Hafize Nalan Güneş; Burcu Gökçe Çokal; Tahir Kurtuluş Yoldaş; İlker Durak
Journal:  Neurol Sci       Date:  2016-07-16       Impact factor: 3.307

9.  Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.

Authors:  Monia Raffa; Fatma Atig; Ahmed Mhalla; Abdelhamid Kerkeni; Anwar Mechri
Journal:  BMC Psychiatry       Date:  2011-08-02       Impact factor: 3.630

Review 10.  Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.

Authors:  Manfred Gerlach; Walter Maetzler; Karl Broich; Harald Hampel; Lucas Rems; Torsten Reum; Peter Riederer; Albrecht Stöffler; Johannes Streffer; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-07-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.